Volume 43, Issue 2 pp. 318-325
ORIGINAL ARTICLE

Detailed profile of cognitive dysfunction in children with aspartylglucosaminuria

Elina Leena Harjunen

Corresponding Author

Elina Leena Harjunen

Division of Child Neurology, Helsinki University Hospital, Helsinki, Finland

Correspondence

Elina Leena Harjunen, Division of Child Neurology, Helsinki University Hospital, Helsinki, Finland.

Email: [email protected]

Search for more papers by this author
Minna Laine

Minna Laine

Division of Child Neurology, Helsinki University Hospital, Helsinki, Finland

Search for more papers by this author
Ritva Tikkanen

Ritva Tikkanen

Institute of Biochemistry, Medical Faculty, University of Giessen, Giessen, Germany

Search for more papers by this author
Päivi Helenius

Päivi Helenius

Division of Child Neurology, Helsinki University Hospital, Helsinki, Finland

Search for more papers by this author
First published: 15 August 2019
Citations: 8
Communicating Editor: Manuel Schiff
Funding information Jane and Aatos Erkko Foundation

Abstract

Aspartylglucosaminuria (AGU) is a rare, recessively inherited lysosomal disease with relatively high prevalence in Finnish population. This progressive disease has a vast impact on patient's cognition and physical health, leading to intellectual disability and shorter life expectancy. Cognitive functions of 21 7- to 14-year-old children with AGU were studied cross-sectionally using Wechsler's Intelligence Scale for Children IV and the results were compared with a standardized Finnish sample. In addition to overall cognitive performance, abilities in discrete cognitive domains, including verbal comprehension, perceptual reasoning, working memory, and processing speed, were examined. The results showed that despite the very low overall level of cognitive performance, there were notable differences between individuals. All those children whose performance was closer to their own age level were 7 to 10 years old. Processing speed appeared more compromised, as compared with verbal comprehension. Furthermore, examining the subtest raw scores, there were no significant positive correlations between age and subtest scores, suggesting that the developmental level of AGU children could be rather stable throughout ages 7 to 14. This study gives insight to the severe nature of AGU disease. Since younger children performed better compared to their age norms than older children, the results raise a question whether the highest peak in cognitive functions is reached at an earlier age than previously thought.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.